SCSee Ching Chan

See Ching Chan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


See Ching Chan has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy

    by Kin-Pan Au, See-Ching Chan, Kenneth Siu-Ho Chok, Albert Chi-Yan Chan, Tan-To Cheung, Kelvin Kwok-Chai Ng, Chung-Mau Lo

    Objective. To study the correlations and discrepancies between Child-Pugh system and indocyanine green (ICG) clearance test in assessing liver function reserve and explore the possibility of combining two systems to gain an overall liver function assessment. Design. Retrospective analysis of 2832 hepatocellular carcinoma (HCC) patients graded as Child-Pugh A and Child-Pugh B with ICG clearance test being performed was conducted. Results. ICG retention rate at 15 minutes (ICG15) correlates with Child-Pugh score, however, with a large variance. Platelet count improves the correlation between Child-Pugh score and ICG15. ICG15 can be estimated using the following regression formula: estimated ICG15 (eICG15) = 45.1 + 0.435 × bilirubin − 0.917 × albumin + 0.491 × prothrombin time − 0.0283 × platelet (R2=0.455). Patients with eICG15 >20.0% who underwent major hepatectomy had a tendency towards more posthepatectomy liver failure (4.1% versus 8.0%, p=0.09) and higher in-hospital mortality (3.7% versus 8.0%, p=0.052). They also had shorter median overall survival (5.10±0.553 versus 3.01±0.878 years, p=0.015) and disease-free survival (1.37±0.215 versus 0.707±0.183 years, p=0.018). Conclusion. eICG15 can be predicted from Child-Pugh parameters and platelet count. eICG15 correlates with in-hospital mortality after major hepatectomy and predicts long-term survival.


  • Lipid profiles of donors and recipients of liver transplant: like father like son

    by Kevin K. W. Chu, See Ching Chan, Sui Ling Sin, Albert C. Y. Chan, Kenneth S. H. Chok, Ignatius K. P. Cheng, Chung Mau Lo

    Dyslipidemia is common in liver transplant recipients. This retrospective study investigates whether donors play a role.


  • Open Access

    Adult-to-adult living donor liver transplantation: Operative techniques to optimize the recipient's outcome

    by SeeChing Chan, PengSoon Koh

    Adult-to-adult living donor liver transplantation (LDLT) is widely accepted today with good outcomes and safety reported worldwide for both donor and recipient. Nonetheless, it remained a highly demanding technical and complex surgery if undertaken. The last two decades have seen an increased in adult-to-adult LDLT following our first report of right lobe LDLT in overcoming graft size limitation in adults. In this article, we discussed the operative techniques and challenges of adult right lobe LDLT incorporating the middle hepatic vein, which is practiced in our center for the recipient operation. The various issues and challenges faced by the transplant surgeon in ensuring good recipient outcome are explored and discussed here as well. Hence, it is important to understand that a successful recipient operation is dependent of multifactorial events starting at the preoperative stage of planning, understanding the intraoperative technical challenges and the physiology of flow modulation that goes hand-in-hand with the operation. Therefore, one needs to arm oneself with all the possible knowledge in overcoming these technical challenges and the ability to be flexible and adaptable during LDLT by tailoring the needs of each patient individually.


  • Open Access

    New insights after the first 1000 liver transplantations at The University of Hong Kong

    by See Ching Chan, Tan To Cheung, Albert C.Y. Chan, Kenneth S.H. Chok, William W. Sharr, James Y.Y. Fung, Chi Leung Liu, Sheung Tat Fan, Chung Mau Lo


  • Open Access

    Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance

    by Patrick Ho Yu Chung, See Ching Chan, Kwong Leung Chan, Yuk Sing Chan, Janette Siu Yin Kwok, Chung Mau Lo

    Pediatric recipients who recovered from PTLD after liver transplant and twice the number of recipients who never had PTLD were recruited. Their immune statuses were measured by ImmuKnow (measurement of adenosine 5-triphospate level produced CD4+ T helper cells), and the results were divided into 3 groups, “low” (≤225 ng/mL), “moderate” (226 to 524 ng/mL), and “high” (≥525 ng/mL). The results of both groups were compared and analyzed. Nine PTLD recipients and 20 non-PTLD recipients were recruited. There were no significant differences in terms of sex and age between the 2 groups. The majority of PTLD recipients (88.9%) had “low” immune status responses, and none of them had “high” responses. For non-PTLD recipients, more than half (55%) had “moderate” immune status responses. The median value of adenosine 5-triphospate levels was significantly lower in the PTLD group (119 ng/mL vs 380.5 ng/mL P = 0.014), and their trough immunosuppressant level was also lower (3.8 μg/L vs 7.7 μg/L; P = 0.004). None of the patients in either group had abnormal liver enzymes (aspartate aminotransferase/alanine aminotransferase) to suggest graft rejection. Patients who recovered from PTLD have a lower CD4 T-cell activity compared with those who have not suffered from PTLD. Under careful monitoring, their immunosuppressant levels can be kept at low levels to prevent recurrence of PTLD.


  • Minimalist approach to donor hepatectomy

    by See Ching Chan, Sheung Tat Fan

  • Clinical factors affecting rejection rates in liver transplantation

    by Kin Pan Au, See-Ching Chan, Kenneth Siu-Ho Chok, William Wei Sharr, Wing-Chiu Dai, Sui-Ling Sin, Tiffany Cho-Lam Wong, Chung-Mau Lo


  • The friendly incidental portal vein thrombus in liver transplantation

    by Peng Soon Koh, See Ching Chan, Kenneth Siu‐Ho Chok, William Wei Sharr, Tiffany Cho-Lam Wong, Sui Ling Sin, Chung Mau Lo

    Improved outcomes have been shown in liver transplantation (LT) with portal vein thrombosis (PVT). However, PVT is still discovered incidentally during surgery despite careful preoperative imaging. Data are limited comparing the outcomes of incidental PVT with PVT diagnosed via preoperative imaging before LT. This study aims to compare the overall outcomes of patients with PVT. From 2008 to 2012, 369 patients had LT, and 58 patients with PVT were identified. They were divided into those with non‐PVT (group 0; n = 311), preoperatively identified PVT (group 1; n = 28), and incidental PVT (group 2; n = 30). The demographics, characteristics, preoperative assessment, and postoperative outcomes were compared. A survival analysis was also performed. Baseline characteristics and preoperative evaluations of all 3 groups were comparable (P > 0.05) except for Model for End‐Stage Liver Disease score, tumor status, platelet levels, and serum bilirubin. A multivariate analysis only showed a high serum bilirubin level to be a predictor of PVT (P = 0.004; odds ratio, 3.395; 95% confidence interval, 1.467‐7.861). Postoperative outcomes were also comparable (P > 0.05). Compared to group 2, group 1 had more patients with a Yerdel classification of 3 or 4 with more extensive surgical intervention required (P = 0.02). The survival analysis in all 3 groups was comparable with 5‐year survival rate of 87.4%, 84.6%, and 91.8% in group 0, 1, and 2, respectively (P = 0.66). In conclusion, recipients with PVT undergoing LT can have similar outcomes as the non‐PVT patients even if PVTs were discovered incidentally. Discovery of incidental PVT only requires thrombectomy with no substantial change of treatment strategy, and the outcome is not adversely affected because most incidental PVTs are of a lower Yerdel grade. Preoperative imaging is useful to identify those with a higher Yerdel grade to allow planning of surgical strategy during transplantation.Liver Transpl 21:944‐952, 2015. © 2015 AASLD.


  • Transplantation of a 2-year-old deceased-donor liver to a 61-year-old male recipient

    by Wing Chiu Dai, William W. Sharr, Kenneth S.H. Chok, Tan To Cheung, James Y.Y. Fung, Albert C.Y. Chan, See Ching Chan, Chung Mau Lo


  • Recovering the Recovering Liver Graft

    by See Ching Chan

    The shortage of liver grafts from deceased donors is universal. A deceased‐donor whole liver from an otherwise healthy brain‐dead donor is ideal for transplantation. This situation however is very uncommon since deceased donors often have comorbidities like hypertension, diabetes, or multiple injuries. On the occasion when a whole liver with excellent function is available for transplantation, splitting it into two grafts for two recipients is often done in order to maximize utilization.